<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35886618</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>14</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>The Advantages of the Zero-COVID-19 Strategy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8767</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph19148767</ELocationID><Abstract><AbstractText><b>Introduction</b>: To curb the COVID-19 pandemic, countries across the globe have adopted either a mitigation or anelimination policy, such as the zero-COVID-19 strategy. However, further research is needed to systematically investigate the advantages of the zero-COVID-19 strategy in the literature. To bridge the research gap, this study examines the zero-COVID-19 strategy in terms of its advantages as a global anti-pandemic framework. <b>Methods</b>: A literature review was conducted in PubMed, PsycINFO, and Scopus to locate academic articles that discussed the advantages of the zero-COVID-19 strategy. Braun and Clarke's thematic analysis approach was adopted to guide the data analysis process. <b>Results</b>: The findings of our study show that the advantages of the zero-COVID-19 strategy range from short-term (e.g., limited virus infections, hospitalizations, and deaths), to medium-term (e.g., reduced presence of other infectious diseases), and long-term (e.g., low incidence of long COVID-19). While local residents mainly leverage these advantages, they also impact the global community (e.g., stable global supply of essentials, such as COVID-19 vaccines). <b>Conclusions</b>: COVID-19 is catastrophic, yet controllable. Our study examined the advantages of the zero-COVID-19 strategy from a nuanced perspective and discussed how these advantages benefit both the local and the global community in pandemic control and management. Future studies could investigate the shortcomings of the zero-COVID-19 strategy, especially its unintended consequences, such as adverse impacts on vulnerable populations' mental health, so that society could more efficiently, economically, and empathetically capitalize on the potential of the zero-COVID-19 strategy for the betterment of personal and public health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Zhaohui</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-2005-9504</Identifier><AffiliationInfo><Affiliation>School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center on Smart and Connected Health Technologies, Mays Cancer Center, School of Nursing, UT Health San Antonio, San Antonio, TX 78229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheshmehzangi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2657-4865</Identifier><AffiliationInfo><Affiliation>Faculty of Science and Engineering, University of Nottingham Ningbo China, Ningbo 315100, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network for Education and Research on Peace and Sustainability (NERPS), Hiroshima University, Hiroshima 739-8530, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDonnell</LastName><ForeName>Dean</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Humanities, South East Technological University, R93 V960 Carlow, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Junaid</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8580-7529</Identifier><AffiliationInfo><Affiliation>Prime Institute of Public Health, Peshawar Medical College, Warsak Road, Peshawar 25160, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x160;egalo</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9280-3278</Identifier><AffiliationInfo><Affiliation>Faculty of Health Studies, University of Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Yu-Tao</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, Centre for Cognitive and Brain Sciences, Institute of Advanced Studies in Humanities and Social Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Veiga</LastName><ForeName>Claudimar Pereira</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0002-4960-5954</Identifier><AffiliationInfo><Affiliation>Funda&#xe7;&#xe3;o Dom Cabral-FDC, Av. Princesa Diana, 760 Alphaville, Lagoa dos Ingleses, Nova Lima 34018-006, MG, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">public health policies</Keyword><Keyword MajorTopicYN="N">virus elimination</Keyword><Keyword MajorTopicYN="N">zero-COVID-19 strategy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35886618</ArticleId><ArticleId IdType="pmc">PMC9317662</ArticleId><ArticleId IdType="doi">10.3390/ijerph19148767</ArticleId><ArticleId IdType="pii">ijerph19148767</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  The True Death Toll of COVID-19: Estimating Global Excess Mortality.  [(accessed on 30 April 2022)];2022  Available online:  https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality.</Citation></Reference><Reference><Citation>Dowdle W.R. The principles of disease elimination and eradication. Bull. World Health Organ. 1998;76((Suppl. S2)):22&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2305684</ArticleId><ArticleId IdType="pubmed">10063669</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng E. Can China&#x2019;s Zero Tolerance Approach to Fighting the Delta Variant Work Forever? 2021.  [(accessed on 4 October 2021)].  Available online:  https://www.npr.org/2021/08/25/1031067091/china-delta-coronavirus-variant-mass-testing-lockdown.</Citation></Reference><Reference><Citation>Wong T. China: How Delta Threatens a Prized Zero COVID Strategy. 2021.  [(accessed on 4 October 2021)].  Available online:  https://www.bbc.com/news/world-asia-china-58095909.</Citation></Reference><Reference><Citation>Global Times  Virus Resurgence Raises Urgency of Improving Epidemic-Control Efficiency: Global Times Editorial. 2021.  [(accessed on 4 October 2021)].  Available online:  https://www.globaltimes.cn/page/202108/1230253.shtml.</Citation></Reference><Reference><Citation>Liu C. China&#x2019;s &#x2018;Zero Tolerance&#x2019; COVID-19 Policy to Safeguard the Country to Withstand Epidemic Flare-Ups amid Holidays. 2021.  [(accessed on 5 October 2021)].  Available online:  https://www.globaltimes.cn/page/202109/1234763.shtml.</Citation></Reference><Reference><Citation>Kupferschmidt K., Cohen J. China&#x2019;s Aggressive Measures Have Slowed the Coronavirus. They May Not Work in Other Countries. 2020.  [(accessed on 6 October 2021)].  Available online:  https://www.science.org/news/2020/03/china-s-aggressive-measures-have-slowed-coronavirus-they-may-not-work-other-countries.</Citation></Reference><Reference><Citation>Skegg D.C.G., Hill P.C. Defining COVID-19 elimination. BMJ. 2021;374:n1794. doi: 10.1136/bmj.n1794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1794</ArticleId><ArticleId IdType="pubmed">34266880</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam S.N., Wai H., Cheng J., Helgason K.S., Hunt N., Kawamura H., LaFleur M. Variations in COVID Strategies: Determinants and Lessons. United Nations; New York, NY, USA: 2020.</Citation></Reference><Reference><Citation>World Health Organization  Global Framework for Multi-Disease Elimination.  [(accessed on 7 October 2021)];2020  Available online:  https://www.who.int/docs/default-source/ntds/leprosy/global-consultation-on-global-leprosy-strategy-2021-2030/08-global-framework-multi-disease-elimination.pdf.</Citation></Reference><Reference><Citation>Oliu-Barton M., Pradelski B.S., Aghion P., Artus P., Kickbusch I., Lazarus J.V., Sridhar D., Vanderslott S. SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties. Lancet. 2021;397:2234&#x2013;2236. doi: 10.1016/S0140-6736(21)00978-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00978-8</ArticleId><ArticleId IdType="pmc">PMC8081398</ArticleId><ArticleId IdType="pubmed">33932328</ArticleId></ArticleIdList></Reference><Reference><Citation>Wee S.-L., Chen E. After Months as a COVID Success Story, China Tries to Tame Delta. 2021.  [(accessed on 3 October 2021)].  Available online:  https://www.nytimes.com/2021/08/04/world/asia/china-delta-covid-testing-outbreak.html.</Citation></Reference><Reference><Citation>Bergwerk M., Gonen T., Lustig Y., Amit S., Lipsitch M., Cohen C., Mandelboim M., Levin E.G., Rubin C., Indenbaum V., et al. COVID-19 breakthrough infections in vaccinated health care workers. N. Engl. J. Med. 2021;385:1474&#x2013;1484. doi: 10.1056/NEJMoa2109072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109072</ArticleId><ArticleId IdType="pmc">PMC8362591</ArticleId><ArticleId IdType="pubmed">34320281</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg E.S., Holtgrave D.R., Dorabawila V., Conroy M., Greene D., Lutterloh E., Backenson B., Hoefer D., Morne J., Bauer U., et al. New COVID-19 cases and hospitalizations among adults, by vaccination status&#x2014;New York, May 3&#x2013;July 25, 2021. Morb. Mortal. Wkly. Rep. 2021;70:1306&#x2013;1311. doi: 10.15585/mmwr.mm7037a7.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7037a7</ArticleId><ArticleId IdType="pmc">PMC8445378</ArticleId><ArticleId IdType="pubmed">34529645</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosh-Nissimov T., Orenbuch-Harroch E., Chowers M., Elbaz M., Nesher L., Stein M., Maor Y., Cohen R., Hussein K., Weinberger M., et al. BNT162b2 vaccine breakthrough: Clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel. Clin. Microbiol. Infect. 2021;27:1652&#x2013;1657. doi: 10.1016/j.cmi.2021.06.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.06.036</ArticleId><ArticleId IdType="pmc">PMC8261136</ArticleId><ArticleId IdType="pubmed">34245907</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez A.R. Omicron&#x2019;s Spread Drives the Global Daily Average of Known New Cases Past a Staggering 2 Million. 2022.  [(accessed on 10 January 2022)].  Available online:  https://www.nytimes.com/2022/01/08/world/omicrons-spread-drives-the-global-daily-average-of-known-new-cases-past-a-staggering-2-million.html.</Citation></Reference><Reference><Citation>World Health Organization  Listings of WHO&#x2019;s Response to COVID-19.  [(accessed on 6 October 2021)];2021  Available online:  https://www.who.int/news/item/29-06-2020-covidtimeline.</Citation></Reference><Reference><Citation>Thielen F.W., Van Mastrigt G.A.P.G., Burgers L.T., Bramer W.M., Majoie H.J.M., Evers S.M.A.A., Kleijnen J. How to prepare a systematic review of economic evaluations for clinical practice guidelines: Database selection and search strategy development (part 2/3) Expert Rev. Pharm. Outcomes Res. 2016;16:705&#x2013;721. doi: 10.1080/14737167.2016.1246962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737167.2016.1246962</ArticleId><ArticleId IdType="pubmed">27805466</ArticleId></ArticleIdList></Reference><Reference><Citation>National Library of Medicine  Public Health Emergency COVID-19 Initiative.  [(accessed on 26 June 2022)];2020  Available online:  https://www.ncbi.nlm.nih.gov/pmc/about/covid-19/</Citation></Reference><Reference><Citation>Gusenbauer M., Haddaway N.R. Which academic search systems are suitable for systematic reviews or meta-analyses? Evaluating retrieval qualities of Google Scholar, PubMed, and 26 other resources. Res. Synth. Methods. 2020;11:181&#x2013;217. doi: 10.1002/jrsm.1378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1378</ArticleId><ArticleId IdType="pmc">PMC7079055</ArticleId><ArticleId IdType="pubmed">31614060</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz-Katz G., Bhatt S., Ratmann O., Brauner J.M., Flaxman S., Mishra S., Sharma M., Mindermann S., Bradley V., Vollmer M., et al. Is the cure really worse than the disease? The health impacts of lockdowns during COVID-19. BMJ Glob. Health. 2021;6:e006653. doi: 10.1136/bmjgh-2021-006653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-006653</ArticleId><ArticleId IdType="pmc">PMC8292804</ArticleId><ArticleId IdType="pubmed">34281914</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mustapha A.I., Tijani A.A., Oyewo M., Ibrahim A., Elelu N., Ogundijo O.A., Awosanya E., Heikinheimo A., Adetunji V.O. Nigeria&#x2019;s race to zero COVID-19 cases: True disease burden or testing failure? J. Glob. Health. 2021;11:03094. doi: 10.7189/jogh.11.03094.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.11.03094</ArticleId><ArticleId IdType="pmc">PMC8364253</ArticleId><ArticleId IdType="pubmed">34408855</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V., Clarke V. Using Thematic Analysis in Psychology. Qual. Res. Psychol. 2006;3:77&#x2013;101. doi: 10.1191/1478088706qp063oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki T. Dynamic zero COVID policy in the fight against COVID. Lancet Respir. Med. 2022;10:e58&#x2013;e59. doi: 10.1016/S2213-2600(22)00142-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00142-4</ArticleId><ArticleId IdType="pmc">PMC9020804</ArticleId><ArticleId IdType="pubmed">35460629</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., Deng X., Yang J., Sun K., Liu H., Chen Z., Peng C., Chen X., Wu Q., Zou J., et al. Modeling transmission of SARS-CoV-2 Omicron in China. Nat. Med. 2022 doi: 10.1038/s41591-022-01855-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01855-7</ArticleId><ArticleId IdType="pmc">PMC9307473</ArticleId><ArticleId IdType="pubmed">35537471</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason B., Stott S., Beamish R. Reduced presentations with fractures or orthopaedic infections to a major children&#x2019;s hospital during a national COVID-19 elimination strategy. ANZ J. Surg. 2022;92:206&#x2013;211. doi: 10.1111/ans.17354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.17354</ArticleId><ArticleId IdType="pmc">PMC8646530</ArticleId><ArticleId IdType="pubmed">34725908</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.-L., Kuo H.-C. Public health interventions for COVID-19 reduce Kawasaki disease in Taiwan. Children. 2021;8:623. doi: 10.3390/children8080623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children8080623</ArticleId><ArticleId IdType="pmc">PMC8392252</ArticleId><ArticleId IdType="pubmed">34438515</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee M. Achieving zero COVID is not easy, but the alternative is far worse. BMJ. 2020;371:m3859. doi: 10.1136/bmj.m3859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3859</ArticleId><ArticleId IdType="pubmed">33028538</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig M., Winkler A. The impact of government responses to the COVID-19 pandemic on GDP growth: Does strategy matter? PLoS ONE. 2021;16:e0259362. doi: 10.1371/journal.pone.0259362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259362</ArticleId><ArticleId IdType="pmc">PMC8570518</ArticleId><ArticleId IdType="pubmed">34739509</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson N., Summers J.A., Grout L., Baker M.G. Bumper issue of COVID-19 pandemic studies of relevance to Aotearoa New Zealand. N. Z. Med. J. 2021;134:9&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">34239141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding D., Zhang R. China&#x2019;s COVID-19 control strategy and its impact on the global pandemic. Front. Public Health. 2022;10:483. doi: 10.3389/fpubh.2022.857003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.857003</ArticleId><ArticleId IdType="pmc">PMC8964044</ArticleId><ArticleId IdType="pubmed">35359767</ArticleId></ArticleIdList></Reference><Reference><Citation>AlTakarli N.S. China&#x2019;s response to the COVID-19 outbreak: A model for epidemic preparedness and management. Dubai Med. J. 2020;3:44&#x2013;49. doi: 10.1159/000508448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000508448</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson R.M., Heesterbeek H., Klinkenberg D., Hollingsworth T.D. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395:931&#x2013;934. doi: 10.1016/S0140-6736(20)30567-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30567-5</ArticleId><ArticleId IdType="pmc">PMC7158572</ArticleId><ArticleId IdType="pubmed">32164834</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M.G., Wilson N., Blakely T. Elimination could be the optimal response strategy for COVID-19 and other emerging pandemic diseases. BMJ. 2020;371:m4907. doi: 10.1136/bmj.m4907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4907</ArticleId><ArticleId IdType="pubmed">33561814</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., Hu S., Lin Q., Ren T., Chen L. China&#x2019;s &#x2018;dynamic zero COVID-19 strategy&#x2019; will face greater challenges in the future. J. Infect. 2022;85:e13&#x2013;e14. doi: 10.1016/j.jinf.2022.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.04.025</ArticleId><ArticleId IdType="pmc">PMC9015719</ArticleId><ArticleId IdType="pubmed">35447231</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlton L.H., Chen T., Whitcombe A.L., McGregor R., Scheurich G., Sheen C.R., Dickson J.M., Bullen C., Chiang A., Exeter D.J., et al. Charting elimination in the pandemic: A SARS-CoV-2 serosurvey of blood donors in New Zealand. Epidemiol. Infect. 2021;149:e173. doi: 10.1017/S0950268821001643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821001643</ArticleId><ArticleId IdType="pmc">PMC8365046</ArticleId><ArticleId IdType="pubmed">34668464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Shi L., Zhang Y., Wang X., Jiao J., Yang M., Sun G. Comparison of public health containment measures of COVID-19 in China and India. Risk Manag. Healthc. Policy. 2021;14:3323&#x2013;3332. doi: 10.2147/RMHP.S326775.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RMHP.S326775</ArticleId><ArticleId IdType="pmc">PMC8367213</ArticleId><ArticleId IdType="pubmed">34408516</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Shi L., Zhang Y., Wang X., Sun G. A cross-country core strategy comparison in China, Japan, Singapore and South Korea during the early COVID-19 pandemic. Glob. Health. 2021;17:22. doi: 10.1186/s12992-021-00672-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12992-021-00672-w</ArticleId><ArticleId IdType="pmc">PMC7897890</ArticleId><ArticleId IdType="pubmed">33618688</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Shi L., Zhang Y., Wang X., Sun G. Policy disparities in response to COVID-19 between China and South Korea. J. Epidemiol. Glob. Health. 2021;11:246&#x2013;252. doi: 10.2991/jegh.k.210322.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.2991/jegh.k.210322.001</ArticleId><ArticleId IdType="pmc">PMC8242108</ArticleId><ArticleId IdType="pubmed">33876595</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.Y., Assefa Y. The heterogeneity of the COVID-19 pandemic and national responses: An explanatory mixed-methods study. BMC Public Health. 2021;21:835. doi: 10.1186/s12889-021-10885-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-10885-8</ArticleId><ArticleId IdType="pmc">PMC8087883</ArticleId><ArticleId IdType="pubmed">33933062</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.-M., Chen Y.-Q. China can prepare to end its zero-COVID policy. Nat. Med. 2022;28:1104&#x2013;1105. doi: 10.1038/s41591-022-01794-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01794-3</ArticleId><ArticleId IdType="pubmed">35383312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng V.C.C., Ip J.D., Chu A.W.H., Tam A.R., Chan W.M., Abdullah S.M.U., Chan B.P.C., Wong S.C., Kwan M.Y.W., Chua G.T., et al. Rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant BA.2 in a single-source community outbreak. Clin. Infect. Dis. 2022:ciac203. doi: 10.1093/cid/ciac203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac203</ArticleId><ArticleId IdType="pmc">PMC8992238</ArticleId><ArticleId IdType="pubmed">35271728</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheshmehzangi A., Zou T., Su Z. Commentary: China&#x2019;s zero-COVID approach depends on Shanghai&#x2019;s outbreak control. Front. Public Health. 2022;10 doi: 10.3389/fpubh.2022.912992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.912992</ArticleId><ArticleId IdType="pmc">PMC9237406</ArticleId><ArticleId IdType="pubmed">35774574</ArticleId></ArticleIdList></Reference><Reference><Citation>Das M. COVID-19 and the elderlies: How safe are Hong Kong&#x2019;s care homes? Front. Public Health. 2022;10:883472. doi: 10.3389/fpubh.2022.883472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.883472</ArticleId><ArticleId IdType="pmc">PMC9013904</ArticleId><ArticleId IdType="pubmed">35444984</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer O. COVID-19: Lockdowns spread in China as omicron tests &#x201c;zero COVID&#x201d; strategy. BMJ. 2022;376:o859. doi: 10.1136/bmj.o859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o859</ArticleId><ArticleId IdType="pubmed">35361680</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald D.A., Wong G.W.K. COVID-19: A tale of two pandemics across the Asia Pacific region. Paediatr. Respir. Rev. 2020;35:75&#x2013;80. doi: 10.1016/j.prrv.2020.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2020.06.018</ArticleId><ArticleId IdType="pmc">PMC7319925</ArticleId><ArticleId IdType="pubmed">32768308</ArticleId></ArticleIdList></Reference><Reference><Citation>Hale T., Angrist N., Goldszmidt R., Kira B., Petherick A., Phillips T., Webster S., Cameron-Blake E., Hallas L., Majumdar S., et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker) Nat. Hum. Behav. 2021;5:529&#x2013;538. doi: 10.1038/s41562-021-01079-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-021-01079-8</ArticleId><ArticleId IdType="pubmed">33686204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan I., Mukaigawara M., King L., Fernandes G., Sridhar D. Hindsight is 2020? Lessons in global health governance one year into the pandemic. Nat. Med. 2021;27:396&#x2013;400. doi: 10.1038/s41591-021-01272-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01272-2</ArticleId><ArticleId IdType="pubmed">33723454</ArticleId></ArticleIdList></Reference><Reference><Citation>Jecker N.S., Au D.K.S. Does Zero-COVID neglect health disparities? J. Med. Ethics. 2022;48:169. doi: 10.1136/medethics-2021-107763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/medethics-2021-107763</ArticleId><ArticleId IdType="pubmed">34815318</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A., Thornley S., Morris A.J., Sundborn G. Should countries aim for elimination in the COVID-19 pandemic? BMJ. 2020;370:m3410. doi: 10.1136/bmj.m3410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3410</ArticleId><ArticleId IdType="pubmed">32909958</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G., Razum O., Jahn A., Zhang Y., Sutton B., Sridhar D., Ariyoshi K., von Seidlein L., M&#xfc;ller O. COVID-19 in Germany and China: Mitigation versus elimination strategy. Glob. Health Action. 2021;14:1875601. doi: 10.1080/16549716.2021.1875601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16549716.2021.1875601</ArticleId><ArticleId IdType="pmc">PMC7833051</ArticleId><ArticleId IdType="pubmed">33472568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallapaty S. China&#x2019;s zero-COVID strategy: What happens next? Nature. 2022;602:15&#x2013;16. doi: 10.1038/d41586-022-00191-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00191-7</ArticleId><ArticleId IdType="pubmed">35087249</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller O., Lu G., Jahn A., Razum O. COVID-19 control: Can Germany learn from China? Int. J. Health Policy Manag. 2020;9:432&#x2013;435. doi: 10.34172/ijhpm.2020.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/ijhpm.2020.78</ArticleId><ArticleId IdType="pmc">PMC7719213</ArticleId><ArticleId IdType="pubmed">32610735</ArticleId></ArticleIdList></Reference><Reference><Citation>Normile D. &#x2018;Zero COVID&#x2019; is getting harder&#x2014;But China is sticking with it. Science. 2021;374:924. doi: 10.1126/science.acx9657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.acx9657</ArticleId><ArticleId IdType="pubmed">34793217</ArticleId></ArticleIdList></Reference><Reference><Citation>Normile D. Can &#x2018;zero COVID&#x2019; countries continue to keep the virus at bay once they reopen? Science. 2022;373 doi: 10.1126/science.acx9109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.acx9109</ArticleId></ArticleIdList></Reference><Reference><Citation>Normile D. China quietly plans a pivot from &#x2018;zero COVID&#x2019;. Science. 2022;375:949. doi: 10.1126/science.adb1762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adb1762</ArticleId><ArticleId IdType="pubmed">35239375</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer G.O. Zero COVID and health inequities: Lessons from Singapore. J. Med. Ethics. 2022;48:174. doi: 10.1136/medethics-2022-108205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/medethics-2022-108205</ArticleId><ArticleId IdType="pubmed">35232771</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu K., Tokuda Y., Shibuya K. Japan should aim to eliminate COVID-19. BMJ. 2021;372:n294. doi: 10.1136/bmj.n294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n294</ArticleId><ArticleId IdType="pubmed">33558342</ArticleId></ArticleIdList></Reference><Reference><Citation>Shokoohi M., Osooli M., Stranges S. COVID-19 pandemic: What can the west learn from the East? Int. J. Health Policy Manag. 2020;9:436&#x2013;438. doi: 10.34172/ijhpm.2020.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/ijhpm.2020.85</ArticleId><ArticleId IdType="pmc">PMC7719217</ArticleId><ArticleId IdType="pubmed">32610736</ArticleId></ArticleIdList></Reference><Reference><Citation>Stobart A., Duckett S. Australia&#x2019;s Response to COVID-19. Health Econ. Policy Law. 2022;17:95&#x2013;106. doi: 10.1017/S1744133121000244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1744133121000244</ArticleId><ArticleId IdType="pmc">PMC8365101</ArticleId><ArticleId IdType="pubmed">34311803</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor L. COVID-19: Hong Kong reports world&#x2019;s highest death rate as zero COVID strategy fails. BMJ. 2022;376:o707. doi: 10.1136/bmj.o707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o707</ArticleId><ArticleId IdType="pubmed">35302043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Z., Lu R., Zhao Y., Zhang C. Diagnostic strategy of SARS-CoV-2 for containment under China&#x2019;s zero-COVID-19 policy. J. Infect. 2022;85:e7&#x2013;e9. doi: 10.1016/j.jinf.2022.04.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.04.044</ArticleId><ArticleId IdType="pmc">PMC9056992</ArticleId><ArticleId IdType="pubmed">35508273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Shi L., Zhang Y., Chen H., Sun G. Policy disparities in fighting COVID-19 among Japan, Italy, Singapore and China. Int. J. Equity Health. 2021;20:33. doi: 10.1186/s12939-020-01374-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-020-01374-2</ArticleId><ArticleId IdType="pmc">PMC7804586</ArticleId><ArticleId IdType="pubmed">33441144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.C., Au A.K.W., Chen H., Yuen L.L.H., Li X., Lung D.C., Chu A.W.H., Ip J.D., Chan W.M., Tsoi H.W., et al. Transmission of Omicron (B.1.1.529)&#x2014;SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: A challenge of elimination strategy of COVID-19. Lancet Reg. Health-West. Pac. 2022;18:100360. doi: 10.1016/j.lanwpc.2021.100360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2021.100360</ArticleId><ArticleId IdType="pmc">PMC8696199</ArticleId><ArticleId IdType="pubmed">34961854</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Z., Li J., Cheng Z.J. Zero-COVID strategy: What&#x2019;s next? Int. J. Health Policy Manag. 2022 doi: 10.34172/ijhpm.2022.6757.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/ijhpm.2022.6757</ArticleId><ArticleId IdType="pmc">PMC10125220</ArticleId><ArticleId IdType="pubmed">35120404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Shi L., Chen H., Wang X., Sun G. Hubei&#x2019;s core response policies in the early stage of COVID-19. Biomed. Res. Int. 2021;2021:6610045. doi: 10.1155/2021/6610045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6610045</ArticleId><ArticleId IdType="pmc">PMC8168471</ArticleId><ArticleId IdType="pubmed">34159196</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Shi L., Chen H., Wang X., Sun G. Policy disparities in response to the first wave of COVID-19 between China and Germany. Int. J. Equity Health. 2021;20:86. doi: 10.1186/s12939-021-01424-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-021-01424-3</ArticleId><ArticleId IdType="pmc">PMC7993854</ArticleId><ArticleId IdType="pubmed">33766049</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Wang H., Wen Z., Gu M., Liu L., Li X. Asymptomatic transmissibility calls for implementing a Zero-COVID strategy to end the current global crisis. Front. Cell. Infect. Microbiol. 2022;12:836409. doi: 10.3389/fcimb.2022.836409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.836409</ArticleId><ArticleId IdType="pmc">PMC9062041</ArticleId><ArticleId IdType="pubmed">35521224</ArticleId></ArticleIdList></Reference><Reference><Citation>Helliwell J.F., Norton M.B., Wang S., Aknin L.B., Huang H. Well-Being Analysis Favours a Virus-Elimination Strategy for COVID-19. National Bureau of Economic Research; Cambridge, MA, USA: 2021. (Working Paper 29092; National Bureau of Economic Research Working Paper Series).</Citation></Reference><Reference><Citation>Our World in Data  Coronavirus Pandemic (COVID-19) 2022.  [(accessed on 27 June 2022)].  Available online:  https://ourworldindata.org/coronavirus.</Citation></Reference><Reference><Citation>The Economist  Tracking COVID-19 Excess Deaths across Countries. 2022.  [(accessed on 30 April 2022)].  Available online:  https://www.economist.com/graphic-detail/coronavirus-excess-deaths-tracker.</Citation></Reference><Reference><Citation>Ball P. Why England&#x2019;s COVID &#x2018;freedom day&#x2019; alarms researchers. Nature. 2021;595:479&#x2013;480. doi: 10.1038/d41586-021-01938-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01938-4</ArticleId><ArticleId IdType="pubmed">34262196</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancino R.S., Su Z., Mesa R., E Tomlinson G., Wang J. The impact of COVID-19 on cancer screening: Challenges and opportunities. JMIR Cancer. 2020;6:e21697. doi: 10.2196/21697.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/21697</ArticleId><ArticleId IdType="pmc">PMC7599065</ArticleId><ArticleId IdType="pubmed">33027039</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobucci G. COVID-19: All non-urgent elective surgery is suspended for at least three months in England. BMJ. 2020;368:m1106. doi: 10.1136/bmj.m1106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1106</ArticleId><ArticleId IdType="pubmed">32188602</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr A., A Smith J., Camaradou J., Prieto-Alhambra D. Growing backlog of planned surgery due to COVID-19. BMJ. 2021;372:n339. doi: 10.1136/bmj.n339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n339</ArticleId><ArticleId IdType="pubmed">33563590</ArticleId></ArticleIdList></Reference><Reference><Citation>University of Oxford  Oxford COVID-19 Government Response Tracker. 2021.  [(accessed on 3 October 2021)].  Available online:  https://www.bsg.ox.ac.uk/research/research-projects/covid-19-government-response-tracker.</Citation></Reference><Reference><Citation>Normile D. China refuses to end harsh lockdowns. Science. 2022;376:333&#x2013;334. doi: 10.1126/science.abq6109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abq6109</ArticleId><ArticleId IdType="pubmed">35446660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma A., Parry J. When Hong Kong&#x2019;s &#x201c;dynamic zero&#x201d; COVID-19 strategy met omicron, low vaccination rates sent deaths soaring. BMJ. 2022;377:o980. doi: 10.1136/bmj.o980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o980</ArticleId><ArticleId IdType="pubmed">35418475</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Q., Cai Z., Li J., Liu Z., Sun S., Chen C., Wang G. The psychological pressures of breast cancer patients during the COVID-19 outbreak in China&#x2014;A comparison with frontline female nurses. Front. Psychiatry. 2020;11 doi: 10.3389/fpsyt.2020.559701.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.559701</ArticleId><ArticleId IdType="pmc">PMC7769818</ArticleId><ArticleId IdType="pubmed">33384620</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Zhao N. Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group? Psychol. Health Med. 2021;26:23&#x2013;34. doi: 10.1080/13548506.2020.1754438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13548506.2020.1754438</ArticleId><ArticleId IdType="pubmed">32286091</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J., Mayer G., Hummel S., Oetjen N., Gronewold N., Zafar A., Schultz J.-H. Mental health burden in different professions during the final stage of the COVID-19 lockdown in China: Cross-sectional survey study. J. Med. Internet Res. 2020;22:e24240. doi: 10.2196/24240.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/24240</ArticleId><ArticleId IdType="pmc">PMC7713530</ArticleId><ArticleId IdType="pubmed">33197231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakib N., Akter T., Zohra F., Bhuiyan A.K.M.I., Mamun M.A., Griffiths M.D. Fear of COVID-19 and depression: A comparative study among the general population and healthcare professionals during COVID-19 pandemic crisis in Bangladesh. Int. J. Ment. Health Addict. 2021:1&#x2013;17. doi: 10.1007/s11469-020-00477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11469-020-00477-9</ArticleId><ArticleId IdType="pmc">PMC7894229</ArticleId><ArticleId IdType="pubmed">33642957</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrente M., Sousa P.A., S&#xe1;nchez-Ramos A., Pimentao J., Royuela A., Franco F., Collazo-Lorduy A., Menasalvas E., Provencio M. To burn-out or not to burn-out: A cross-sectional study in healthcare professionals in Spain during COVID-19 pandemic. BMJ Open. 2021;11:e044945. doi: 10.1136/bmjopen-2020-044945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-044945</ArticleId><ArticleId IdType="pmc">PMC7907836</ArticleId><ArticleId IdType="pubmed">33627353</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M. In Alaska&#x2019;s COVID Crisis, Doctors Must Decide Who Lives and Who Dies. 2021.  [(accessed on 5 October 2021)].  Available online:  https://www.nytimes.com/2021/10/03/us/coronavirus-crisis-alaska.html.</Citation></Reference><Reference><Citation>Torjesen I. COVID-19 vaccine shortages: What is the cause and what are the implications? BMJ. 2021;372:n781. doi: 10.1136/bmj.n781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n781</ArticleId><ArticleId IdType="pubmed">33741547</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson D. Supply Chain Issues Bring Shortages of Drugs, Devices to U.S. Hospitals. 2021.  [(accessed on 30 December 2021)].  Available online:  https://www.usnews.com/news/health-news/articles/2021-11-04/supply-chain-issues-bring-shortages-of-drugs-devices-to-us-hospitals.</Citation></Reference><Reference><Citation>Holt A. Care Staff Shortage Harms Services for Thousands, Say Managers. 2021.  [(accessed on 25 October 2021)].  Available online:  https://www.bbc.com/news/health-58891702.</Citation></Reference><Reference><Citation>Su Z., McDonnell D., Li X., Bennett B., &#x160;egalo S., Abbas J., Cheshmehzangi A., Xiang Y.-T. COVID-19 vaccine donations&#x2014;Vaccine empathy or vaccine diplomacy? A narrative literature review. Vaccines. 2021;9:1024. doi: 10.3390/vaccines9091024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9091024</ArticleId><ArticleId IdType="pmc">PMC8470866</ArticleId><ArticleId IdType="pubmed">34579261</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg S.K., Palm P., Nygaard U., Bundgaard H., Petersen M.N.S., Rosenkilde S., Thorsted A.B., Ersb&#xf8;ll A.K., Thygesen L.C., Nielsen S.D., et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0&#x2013;14 years and matched controls in Denmark (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health. 2022 doi: 10.1016/S2352-4642(22)00154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., Zhang H., Ren L., Guo L., Liu M., Wang Y., Cui D., Wang Y., et al. Health outcomes in people 2 years after surviving hospitalization with COVID-19: A longitudinal cohort study. Lancet Respir. Med. 2022 doi: 10.1016/s2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Simpson F., Mabbitt J., Dunn-Galvin A., Semple C., Warner J.O. Legacy of COVID-19 infection in children: Long-COVID will have a lifelong health/economic impact. Arch. Dis. Child. 2022;107:e2. doi: 10.1136/archdischild-2021-321882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-321882</ArticleId><ArticleId IdType="pubmed">34045207</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. World Health Organization; Geneva, Switzerland: 2021.</Citation></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post-COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years&#x2014;United States, March 2020&#x2013;November 2021. Morb. Mortal. Wkly. Rep. 2022;71:713. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Infectious Diseases. Monkeypox: A neglected old foe. Lancet Infect. Dis. 2022;22:913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9628760</ArticleId><ArticleId IdType="pubmed">35691304</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Diseas Control and Prevention  Monkeypox.  [(accessed on 23 June 2022)];2022  Available online:  https://www.cdc.gov/poxvirus/monkeypox/index.html.</Citation></Reference><Reference><Citation>Bourdin S., Miled S.B., Salhi J. The drivers of policies to limit the spread of COVID-19 in Europe. J. Risk Financ. Manag. 2022;15:67. doi: 10.3390/jrfm15020067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jrfm15020067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdin S., Jeanne L., Nadou F., Noiret G. Does lockdown work? A spatial analysis of the spread and concentration of COVID-19 in Italy. Reg. Stud. 2021;55:1182&#x2013;1193. doi: 10.1080/00343404.2021.1887471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00343404.2021.1887471</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasaulce S., Varma V., Morarescu C., Lin S. How efficient are the lockdown measures taken for mitigating the COVID-19 epidemic? medRxiv. 2020 doi: 10.1101/2020.06.02.20120089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.02.20120089</ArticleId></ArticleIdList></Reference><Reference><Citation>Our World in Data  COVID-19: Stringency Index. 2022.  [(accessed on 11 May 2022)].  Available online:  https://ourworldindata.org/grapher/covid-stringency-index.</Citation></Reference><Reference><Citation>Liu J., Zhang L., Yan Y., Zhou Y., Yin P., Qi J., Wang L., Pan J., You J., Yang J., et al. Excess mortality in Wuhan city and other parts of China during the three months of the COVID-19 outbreak: Findings from nationwide mortality registries. BMJ. 2021;372:n415. doi: 10.1136/bmj.n415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n415</ArticleId><ArticleId IdType="pmc">PMC7900645</ArticleId><ArticleId IdType="pubmed">33627311</ArticleId></ArticleIdList></Reference><Reference><Citation>Keehner J., Horton L.E., Pfeffer M.A., Longhurst C.A., Schooley R.T., Currier J.S., Abeles S.R., Torriani F.J. SARS-CoV-2 infection after vaccination in health care workers in California. N. Engl. J. Med. 2021;384:1774&#x2013;1775. doi: 10.1056/NEJMc2101927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2101927</ArticleId><ArticleId IdType="pmc">PMC8008750</ArticleId><ArticleId IdType="pubmed">33755376</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>